Impact of race on survival in patients with clinically nonmetastatic prostate cancer who deferred primary treatment Academic Article uri icon

Overview

MeSH Major

  • Prostatic Neoplasms

abstract

  • The current data suggested that race did not have a major impact on survival in patients with PCa who deferred primary treatment for clinically nonmetastatic disease.

publication date

  • June 15, 2012

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3623265

Digital Object Identifier (DOI)

  • 10.1002/cncr.26619

PubMed ID

  • 22020835

Additional Document Info

start page

  • 3145

end page

  • 52

volume

  • 118

number

  • 12